An eight-month-old child in Bengaluru has been diagnosed with Human Metapneumovirus (HMPV) amidst a rise in cases in China. The child, undergoing treatment at a private hospital in the city, has no travel history.
The Karnataka Health Department confirmed the case, stating that medical tests returned positive. The Department has reported the case to the Union Health Ministry. However, it remains unclear if this is the same strain of HMPV currently causing a surge in China.
On January 4, China minimised concerns over the increasing HMPV cases, attributing them to an “annual seasonal reoccurrence.” A Chinese foreign ministry official linked the rise to the winter season and assured tourists and citizens that travelling in the country is safe.
In India, the National Centre for Disease Control (NCDC) announced on January 3 that it is monitoring respiratory and seasonal influenza cases while staying in contact with international agencies regarding the HMPV outbreak in China. A senior NCDC official stated that the situation is being closely observed, and updates will be validated accordingly.
Dr Atul Goel, Director General of Health Services (DGHS), explained that HMPV is similar to other respiratory viruses causing common cold symptoms, which may lead to flu-like effects in young children and the elderly. He urged the public to take standard precautions against respiratory infections, such as avoiding contact with others when experiencing symptoms like cough and cold. He also emphasised practising respiratory etiquette and using regular medications for cold and fever.
Also Read: Delhi authorities issue guidelines to prevent HMPV breakout
Meanwhile, Delhi health authorities issued an advisory to ensure readiness for health challenges linked to HMPV and other respiratory viruses. Dr Vandana Bagga, Director General of Health Services, held a meeting with chief district medical officers and the state programme officer of IDSP on Sunday to review preparations for addressing respiratory illnesses in the city.
Hospitals have been instructed to report Influenza-like Illness (ILI) and Severe Acute Respiratory Infection (SARI) cases on the IHIP Portal, adhere to strict isolation protocols, and implement universal precautions for suspected cases. Proper documentation of SARI and lab-confirmed influenza cases is mandatory to facilitate accurate monitoring. Hospitals must also ensure the availability of essential medicines, such as paracetamol, antihistamines, bronchodilators, and cough syrups for mild cases, as well as oxygen for severe cases.
